R. Gelisgen Et Al. , "Circulating oxidized LDL and antibodies against oxidized LDL in type 2 diabetes patients with and without coronary artery disease," 32nd Congress of the Federation-of-European-Biochemical-Societies (FEBS) , vol.274, Vienna, Austria, pp.265, 2007
Gelisgen, R. Et Al. 2007. Circulating oxidized LDL and antibodies against oxidized LDL in type 2 diabetes patients with and without coronary artery disease. 32nd Congress of the Federation-of-European-Biochemical-Societies (FEBS) , (Vienna, Austria), 265.
Gelisgen, R., Cimen, B., Yumuk, V., Bolayirli, M., Hacibekiroglu, M., & Burcak, G., (2007). Circulating oxidized LDL and antibodies against oxidized LDL in type 2 diabetes patients with and without coronary artery disease . 32nd Congress of the Federation-of-European-Biochemical-Societies (FEBS) (pp.265). Vienna, Austria
Gelisgen, R. Et Al. "Circulating oxidized LDL and antibodies against oxidized LDL in type 2 diabetes patients with and without coronary artery disease," 32nd Congress of the Federation-of-European-Biochemical-Societies (FEBS), Vienna, Austria, 2007
Gelisgen, R. Et Al. "Circulating oxidized LDL and antibodies against oxidized LDL in type 2 diabetes patients with and without coronary artery disease." 32nd Congress of the Federation-of-European-Biochemical-Societies (FEBS) , Vienna, Austria, pp.265, 2007
Gelisgen, R. Et Al. (2007) . "Circulating oxidized LDL and antibodies against oxidized LDL in type 2 diabetes patients with and without coronary artery disease." 32nd Congress of the Federation-of-European-Biochemical-Societies (FEBS) , Vienna, Austria, p.265.
@conferencepaper{conferencepaper, author={R. Gelisgen Et Al. }, title={Circulating oxidized LDL and antibodies against oxidized LDL in type 2 diabetes patients with and without coronary artery disease}, congress name={32nd Congress of the Federation-of-European-Biochemical-Societies (FEBS)}, city={Vienna}, country={Austria}, year={2007}, pages={265} }